Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer
Public ClinicalTrials.gov record NCT00901342. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label Study of Sipuleucel-T in Men With Metastatic Castrate Resistant Prostate Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Multicenter, Open Label, Phase 2 Study of Sipuleucel-T in Men with Metastatic Castrate Resistant Prostate Cancer (CRPC).
Study identification
- NCT ID
- NCT00901342
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 104 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2009 (Type not available)
- Primary completion
- Dec 2014 (Actual)
- Completion
- Jun 2015 (Actual)
- Last update posted
- May 23, 2017
2009 – 2015
United States locations
- U.S. sites
- 18
- U.S. states
- 14
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| The University of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| Oncology Specialists, S.C. | Park Ridge | Illinois | 60068 | — |
| Indiana University Department of Urology | Indianapolis | Indiana | 46202 | — |
| Maine Center for Cancer Medicine | Scarborough | Maine | 04074 | — |
| Hematology Oncology Consultants | Greenbelt | Maryland | 20770 | — |
| Myron I. Murdock MD LLC | Greenbelt | Maryland | 20770 | — |
| John Theurer Cancer Center at Hackensack | Hackensack | New Jersey | 07601 | — |
| NYU Cancer Institute | New York | New York | 10016 | — |
| Mount Sinai School of Medicine Department of Urology | New York | New York | 10029 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| GU Oncology Research Program | Durham | North Carolina | 27710 | — |
| Oncology Hematology Care, Inc. | Cincinnati | Ohio | 45242 | — |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | — |
| Texas Oncology, PA - Sammons Cancer Center | Dallas | Texas | 75246 | — |
| Urology of Virginia, PLLC | Virginia Beach | Virginia | 23642 | — |
| Virginia Mason Medical Center Urology and Renal Transplantation | Seattle | Washington | 98101 | — |
| Aurora Advanced Healthcare, Inc | Wauwatosa | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00901342, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 23, 2017 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00901342 live on ClinicalTrials.gov.